AUS
NZ
UK
CA
USA
IND
Healthcare
Can ASX 200 Healthcare Leaders Balance Defence and Demand?
June 03, 2026 01:59 PM AEST| By SamHealthcare combines essential demand, demographic support, and innovation. Leading ASX healthcare companies operate across diagnostics, biotechnology, devices, and digital healthcare.
Healthcare’s Biggest Sell-Off Could Be Creating New Opportunities
June 03, 2026 11:20 AM AEST| By SamHealthcare remains one of the weakest-performing sectors this year, with major companies facing pressure despite ongoing operational and industry developments.
AI Fear or Hidden Strength? Why Pro Medicus Is Back in Focus
June 03, 2026 10:23 AM AEST| By SamPro Medicus continues attracting attention as artificial intelligence transforms healthcare technology. Recent contract developments suggest AI may enhance the company's imaging platform rather than disrupt its long-term position.
Why Ramsay Health Care Remains A Key Healthcare Stock To Watch
June 03, 2026 10:06 AM AEST| By SamRamsay Health Care remains a closely watched healthcare operator as market participants assess private hospital demand, sector trends and broader economic conditions.
Is Micro-X Approaching a Defining Moment in Healthcare Technology?
June 03, 2026 09:42 AM AEST| By SamMicro-X is attracting attention through its specialised imaging technology, expanding commercial activities, and debt-free balance sheet as it advances across healthcare, defence and security markets.
Why Do ASX Healthcare Stocks Command Attention?
June 03, 2026 01:10 AM AEST| By SamExplore ASX healthcare stocks, leading medical technology and biotechnology companies, and the factors that make Australia’s healthcare sector globally recognised.
Leading Healthcare Stocks Across the ASX 200 Sector
June 03, 2026 01:06 AM AEST| By SamExplore major ASX healthcare stocks operating across biotechnology, medical devices, diagnostics, healthcare software, hospital management, and pharmaceutical distribution networks.
Healthcare Stocks Across ASX 300 Draw Fresh Interest
June 03, 2026 12:57 AM AEST| By SamAustralia's healthcare sector remains in focus as CSL, ResMed, Cochlear, Pro Medicus, and Sonic Healthcare continue expanding across biotechnology, diagnostics, and medical technology.
Cochlear’s Innovation Focus Remains in Spotlight Despite Operational Challenges
June 02, 2026 11:42 AM AEST| By SamHighlights,Cochlear continues advancing MRI-compatible hearing implant technology.,Hospital capacity constraints and currency headwinds have weighed on recent performance.,Long-term growth outlook remains tied to expanding demand for implantable hear...
Why Paradigm’s Massive New Share Issue Is Drawing Attention
June 02, 2026 11:24 AM AEST| By SamParadigm Biopharmaceuticals has applied to quote more than forty-three million new shares on the ASX. The move expands tradable securities, enhances liquidity
Why Are ASX 300Healthcare Stocks Back on Market Radar?
June 01, 2026 02:09 PM AEST| By SamASX healthcare stocks remain in focus as biotech updates, regulatory milestones, medical devices, diagnostics, hospitals, and healthcare software shape sector activity.
ASX Healthcare Stocks Across ASX 100 Medical Sector
June 01, 2026 02:08 PM AEST| By SamExplore ASX healthcare stocks across biotechnology, medical devices, diagnostics, hospitals, imaging software, and respiratory care, including CSL, ResMed, Cochlear, Sonic Healthcare, Ramsay, Pro Medicus, and Fisher & Paykel.
ASX Healthcare Stocks Track Global Medical Demand
June 01, 2026 02:08 PM AEST| By SamASX healthcare names remain in focus as CSL, ResMed, Cochlear, Sonic Healthcare, Ramsay, Pro Medicus, and Fisher & Paykel shape sector activity.
Why Pro Medicus’ Latest Healthcare Deal Is Drawing Market Attention
June 01, 2026 10:00 AM AEST| By SamPro Medicus secured another US healthcare contract, highlighting growing adoption of its full Visage platform and cardiology capabilities.
Why Austco Healthcare’s US Expansion Could Be the Bigger Story
June 01, 2026 09:46 AM AEST| By SamAustco Healthcare delivered strong earnings growth while a large US Pulse Mobile deployment highlights growing software and recurring revenue opportunities.
Is Aroa Biosurgery Entering a New Era of Growth?
May 29, 2026 04:35 PM AEST| By SamAroa Biosurgery’s latest financial performance highlights profitability, healthcare market expansion, and evolving valuation discussions as investors assess the company’s long-term growth outlook.
Healthcare Stocks Enter a Catalyst-Rich Phase as Sector Eyes Fresh Momentum
May 29, 2026 04:29 PM AEST| By SamAustralian healthcare stocks are entering a catalyst-heavy phase with regulatory progress, clinical developments, commercial expansion, and innovation-led growth initiatives supporting sector-wide attention.
Why ASX Healthcare Names Keep Drawing Attention
May 29, 2026 02:21 PM AEST| By SamHealthcare companies remain active across radiopharmaceuticals, wound-care devices and diagnostic programs as commercial traction shapes sector discussion.
What Makes These ASX Healthcare Service Names Stand Out?
May 29, 2026 02:15 PM AEST| By SamSonic Healthcare, Healius and Integral Diagnostics operate across pathology, diagnostic services and imaging networks within Australia’s healthcare sector.
ASX 200 Healthcare Leaders Anchoring Market Strength
May 29, 2026 02:10 PM AEST| By SamASX healthcare stocks CSL, COH, and RMD showcase global medical innovation, device leadership, and therapy development across diverse healthcare segments.
Advertise your brand on Kalkine Media